These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38910715)
41. Leukemoid reaction in erythema nodosum leprosum in a leprosy patient. Chaudhary SD; Sen R; Jain VK; Dixit VB Indian J Lepr; 1988 Oct; 60(4):572-6. PubMed ID: 3253336 [TBL] [Abstract][Full Text] [Related]
42. Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker. Vilani-Moreno FR; Brito-de-Souza VN; Silva SMUR; Barbosa ASAA; Sartori BGC; Campanelli AP; Barreto JA; Virmond MDCL Indian J Dermatol Venereol Leprol; 2021; 87(2):190-198. PubMed ID: 33769734 [TBL] [Abstract][Full Text] [Related]
43. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum. Walker SL; Balagon M; Darlong J; Doni SN; Hagge DA; Halwai V; John A; Lambert SM; Maghanoy A; Nery JA; Neupane KD; Nicholls PG; Pai VV; Parajuli P; Sales AM; Sarno E; Shah M; Tsegaye D; Lockwood DN; PLoS Negl Trop Dis; 2015; 9(9):e0004065. PubMed ID: 26351858 [TBL] [Abstract][Full Text] [Related]
44. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. Voorend CG; Post EB PLoS Negl Trop Dis; 2013; 7(10):e2440. PubMed ID: 24098819 [TBL] [Abstract][Full Text] [Related]
45. Therapeutic Dilemma of Refractory Erythema Nodosum Leprosum. Zhu J; Yang D; Shi C; Jing Z Am J Trop Med Hyg; 2017 Jun; 96(6):1362-1364. PubMed ID: 28719256 [TBL] [Abstract][Full Text] [Related]
46. Diagnosis of erythema nodosum leprosum (type 2 reaction) by cytology. Ray R; Mondal RK; Pathak S Acta Cytol; 2014; 58(1):29-32. PubMed ID: 24247108 [TBL] [Abstract][Full Text] [Related]
47. Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept. Chowdhry S; Shukla A; D'souza P; Dhali T; Jaiswal P Int J Mycobacteriol; 2016 Jun; 5(2):223-5. PubMed ID: 27242236 [TBL] [Abstract][Full Text] [Related]
48. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum. Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631 [TBL] [Abstract][Full Text] [Related]
49. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL). Sharma VK; Saha K; Sehgal VN Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448 [TBL] [Abstract][Full Text] [Related]
50. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India. Upputuri B; Pallapati MS; Tarwater P; Srikantam A PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of Polymorphisms in Toll-Like Receptor Genes as Biomarkers of the Response to Treatment of Erythema Nodosum Leprosum. Maciel-Fiuza MF; Costa PDSS; Kowalski TW; Schuler-Faccini L; Bonamigo RR; Vetoratto R; Eidt LM; de Moraes PC; Silveira MIDS; Camargo LMA; Callegari-Jacques SM; Castro SMJ; Vianna FSL Front Med (Lausanne); 2021; 8():713143. PubMed ID: 35141236 [TBL] [Abstract][Full Text] [Related]
52. High dose prednisolone treatment of leprosy patients undergoing reactions is associated with a rapid decrease in urinary nitric oxide metabolites and clinical improvement. Schön T; Leekassa R; Gebre N; Sundqvist T; Bizuneh E; Britton S Lepr Rev; 2000 Sep; 71(3):355-62. PubMed ID: 11105495 [TBL] [Abstract][Full Text] [Related]
53. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient. Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470 [TBL] [Abstract][Full Text] [Related]
54. Tavares IF; Dos Santos JB; Pacheco FDS; Gandini M; Mariante RM; Rodrigues TF; Sales AM; Moraes MO; Sarno EN; Schmitz V Front Med (Lausanne); 2021; 8():711623. PubMed ID: 34692720 [TBL] [Abstract][Full Text] [Related]
55. Reverse Koebner phenomenon in erythema nodosum leprosum. Singh S; Narang T; Dogra S Trans R Soc Trop Med Hyg; 2024 Jan; 118(1):77-79. PubMed ID: 37632458 [TBL] [Abstract][Full Text] [Related]
56. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition. Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830 [TBL] [Abstract][Full Text] [Related]
57. Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum. Bansal F; Narang T; Dogra S; Vinay K; Chhabra S Indian J Dermatol Venereol Leprol; 2018; 84(5):573-577. PubMed ID: 28656911 [TBL] [Abstract][Full Text] [Related]
59. The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum. Rosa TLSA; Mendes MA; Linhares NRC; Rodrigues TF; Dias AA; Leal-Calvo T; Gandini M; Ferreira H; Costa FDMR; Sales AM; Amadeu TP; Schmitz V; Pinheiro RO; Rodrigues LS; Moraes MO; Pessolani MCV Front Med (Lausanne); 2022; 9():899998. PubMed ID: 35733868 [TBL] [Abstract][Full Text] [Related]
60. Erythema Necroticans - A Case Report. Mehta N; Ramachandran R; Srikanth S Indian J Lepr; 2016 Sep; 87(4):255-257. PubMed ID: 29762955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]